Rachel Ellingson Net Worth

The estimated Net Worth of Rachel Ellingson is at least $767 Tausend dollars as of 6 March 2024. Rachel Ellingson owns over 1,419 units of Zimmer Biomet Inc stock worth over $766,649 and over the last 4 years Rachel sold ZBH stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Rachel Ellingson ZBH stock SEC Form 4 insiders trading

Rachel has made over 6 trades of the Zimmer Biomet Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Rachel exercised 1,419 units of ZBH stock worth $149,208 on 6 March 2024.

The largest trade Rachel's ever made was exercising 1,762 units of Zimmer Biomet Inc stock on 25 February 2024 worth over $185,274. On average, Rachel trades about 259 units every 53 days since 2021. As of 6 March 2024 Rachel still owns at least 7,291 units of Zimmer Biomet Inc stock.

You can see the complete history of Rachel Ellingson stock trades at the bottom of the page.

What's Rachel Ellingson's mailing address?

Rachel's mailing address filed with the SEC is 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL, WA, 98021.

Insiders trading at Zimmer Biomet Inc

Over the last 9 years, insiders at Zimmer Biomet Inc have traded over $2,148,754,462 worth of Zimmer Biomet Inc stock and bought 59,988 units worth $7,136,091 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Michael W Michelson und Group Inc Blackstone Group .... On average, Zimmer Biomet Inc executives and independent directors trade stock every 19 days with the average trade being worth of $14,226,269. The most recent stock trade was executed by Zuilen Wilfred Van on 1 July 2024, trading 2,633 units of ZBH stock currently worth $276,860.

What does Zimmer Biomet Inc do?

zimmer biomet is the world’s most trusted brand for personalized bone and joint healthcare solutions. we help people discover and achieve exceptional outcomes. as a leading innovator in musculoskeletal healthcare, we offer a complete portfolio of products for joint reconstruction, bone and skeletal repair, sports medicine, spine, and dental reconstruction. every day, we focus on improving musculoskeletal healthcare. it’s all we do. it’s all we’ve ever done. for nearly 90 years, zimmer biomet has helped people progress beyond their pain and limitations. because it’s not just what we make, it’s what we make possible. zimmer biomet serves healthcare professionals and their patients globally. our worldwide headquarters is in warsaw, indiana, usa.

Complete history of Rachel Ellingson stock trades at Biolife Solutions Inc und Zimmer Biomet Inc

Zimmer Biomet Inc executives and stock owners

Zimmer Biomet Inc executives and other stock owners filed with the SEC include:

• Bryan Hanson,
  President, Chief Executive Officer, Director
• Suketu Upadhyay,
  Chief Financial Officer, Executive Vice President
• Ivan Tornos,
  Group President - Global Businesses and Americas
• Didier Deltort,
  President - Europe, Middle East and Africa
• Bryan C. Hanson,
  Chairman, Pres & CEO
• Chad Phipps,
  Senior Vice President, General Counsel, Secretary
• Sang Yi,
  President, Asia Pacific
• Ivan Tornos,
  Group Pres of Global Bus.es, The Americas & EMEA Region and COO
• Suketu P. Upadhyay,
  Exec. VP & CFO
• Sang Yi,
  Group Pres of Asia Pacific
• Larry Glasscock,
  Independent Non-Executive Chairman of the Board
• Robert Hagemann,
  Independent Director
• Arthur Higgins,
  Independent Director
• Betsy Bernard,
  Independent Director
• Christopher Begley,
  Independent Director
• Gail Boudreaux,
  Independent Director
• Michael Farrell,
  Independent Director
• Michael Michelson,
  Independent Director
• Maria Hilado,
  Independent Director
• Syed Jafry,
  Independent Director
• Carrie Nichol,
  Chief Accounting Officer, Vice President, Controller
• Keri Mattox,
  Senior Vice President - Investor Relations, Chief Communications Officer
• Angela Main,
  Sr. VP, Global Chief Compliance Officer & Associate Gen. Counsel of Asia Pacific
• Chad F. Phipps,
  Sr. VP, Gen. Counsel & Sec.
• Zeeshan Tariq,
  Sr. VP & Chief Information Officer
• Dr. Nitin Goyal M.D.,
  Chief Science, Technology & Innovation Officer
• Derek M. Davis,
  Interim Controller, Chief Accounting Officer, & Principal Accounting Officer
• Louis Shapiro,
  Director
• David C Dvorak,
  President and CEO
• Paul Bisaro,
  Director
• David A. Jr. Nolan,
  Group President
• Adam Rudolph Johnson,
  Group President
• Cecil B Pickett,
  Director
• Katarzyna Mazur Hofsaess,
  Pres., Eur., M. East & Afr.
• Robert D. Delp,
  President, Americas
• Tony W. Collins,
  VP, Controller and CAO
• Jeffrey K. Rhodes,
  Director
• Daniel E. Williamson,
  Group President
• Zuilen Wilfred Van,
  Group Pres, EMEA
• Rachel Ellingson,
  SVP & Chief Strategy Officer
• Aure Bruneau,
  Group President
• Daniel P Florin,
  Exec. VP, CFO
• Sachs Group Incgoldman Sach...,
  
• Stuart G. Kleopfer,
  President, Americas
• Equity Partners 2004 Direct...,
  
• Group Holdings (Sbs) Adviso...,
  
• Group Inc Blackstone Group ...,
  
• Group L.P.Blackstone Manage...,
  
• Capital Partners V L P Blac...,
  
• Acquisition Holding, Llc Lvb,
  
• Sreelakshmi Kolli,
  Director
• Lori Winkler,
  SVP and CHRO
• Devdatt Kurdikar,
  Director
• Derek M Davis,
  Interim Controller & CAO
• Paul A Stellato,
  VP, Controller & CAO
• Mark Bezjak,
  President, Americas